274 related articles for article (PubMed ID: 25271056)
1. Receptor heterodimerization as a novel mechanism for the regulation of Wnt/β-catenin signaling.
Lee K; Shin Y; Cheng R; Park K; Hu Y; McBride J; He X; Takahashi Y; Ma JX
J Cell Sci; 2014 Nov; 127(Pt 22):4857-69. PubMed ID: 25271056
[TBL] [Abstract][Full Text] [Related]
2. Very low density lipoprotein receptor, a negative regulator of the wnt signaling pathway and choroidal neovascularization.
Chen Y; Hu Y; Lu K; Flannery JG; Ma JX
J Biol Chem; 2007 Nov; 282(47):34420-8. PubMed ID: 17890782
[TBL] [Abstract][Full Text] [Related]
3. Tyrosine-based signal mediates LRP6 receptor endocytosis and desensitization of Wnt/β-catenin pathway signaling.
Liu CC; Kanekiyo T; Roth B; Bu G
J Biol Chem; 2014 Oct; 289(40):27562-70. PubMed ID: 25143377
[TBL] [Abstract][Full Text] [Related]
4. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells.
Peröbner I; Karow M; Jochum M; Neth P
Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.
Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312
[TBL] [Abstract][Full Text] [Related]
6. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
[TBL] [Abstract][Full Text] [Related]
7. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
Lu W; Lin C; King TD; Chen H; Reynolds RC; Li Y
Cell Signal; 2012 Dec; 24(12):2291-6. PubMed ID: 22820499
[TBL] [Abstract][Full Text] [Related]
8. LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3's phosphorylation of beta-catenin.
Cselenyi CS; Jernigan KK; Tahinci E; Thorne CA; Lee LA; Lee E
Proc Natl Acad Sci U S A; 2008 Jun; 105(23):8032-7. PubMed ID: 18509060
[TBL] [Abstract][Full Text] [Related]
9. Role of the Rap2/TNIK kinase pathway in regulation of LRP6 stability for Wnt signaling.
Park DS; Seo JH; Hong M; Choi SC
Biochem Biophys Res Commun; 2013 Jun; 436(2):338-43. PubMed ID: 23743195
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane protein 97 exhibits oncogenic properties via enhancing LRP6-mediated Wnt signaling in breast cancer.
Zhu H; Su Z; Ning J; Zhou L; Tan L; Sayed S; Song J; Wang Z; Li H; Sun Q; Liu S; Sha O; Leng F; Chen X; Lu D
Cell Death Dis; 2021 Oct; 12(10):912. PubMed ID: 34615853
[TBL] [Abstract][Full Text] [Related]
11. CDDO-Me Elicits Anti-Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex.
Zhou L; Wang Z; Yu S; Xiong Y; Fan J; Lyu Y; Su Z; Song J; Liu S; Sun Q; Lu D
J Pharmacol Exp Ther; 2020 Apr; 373(1):149-159. PubMed ID: 32015160
[TBL] [Abstract][Full Text] [Related]
12. Lrp4 and Wise interplay controls the formation and patterning of mammary and other skin appendage placodes by modulating Wnt signaling.
Ahn Y; Sims C; Logue JM; Weatherbee SD; Krumlauf R
Development; 2013 Feb; 140(3):583-93. PubMed ID: 23293290
[TBL] [Abstract][Full Text] [Related]
13. Mouse cristin/R-spondin family proteins are novel ligands for the Frizzled 8 and LRP6 receptors and activate beta-catenin-dependent gene expression.
Nam JS; Turcotte TJ; Smith PF; Choi S; Yoon JK
J Biol Chem; 2006 May; 281(19):13247-13257. PubMed ID: 16543246
[TBL] [Abstract][Full Text] [Related]
14. The LRP6 functional mutation rs2302685 contributes to individual susceptibility to alcoholic liver injury related to the Wnt/β-catenin-TCF1-CYP2E1 signaling pathway.
Xu Y; Chen D; Lin XX; Zhao Q; Guo J; Chen LJ; Zhang W; Xiao J; Lian GH; Peng SF; Guo D; Yang H; Obianom O; Shu Y; Chen Y
Arch Toxicol; 2019 Jun; 93(6):1679-1695. PubMed ID: 30976847
[TBL] [Abstract][Full Text] [Related]
15. Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.
Lu W; Lin C; Li Y
Cell Signal; 2014 Jun; 26(6):1303-9. PubMed ID: 24607787
[TBL] [Abstract][Full Text] [Related]
16. LDL receptor-related protein LRP6 regulates proliferation and survival through the Wnt cascade in vascular smooth muscle cells.
Wang X; Adhikari N; Li Q; Hall JL
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2376-83. PubMed ID: 15271658
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-like 4 Is a Wnt Signaling Antagonist that Promotes LRP6 Turnover.
Kirsch N; Chang LS; Koch S; Glinka A; Dolde C; Colozza G; Benitez MDJ; De Robertis EM; Niehrs C
Dev Cell; 2017 Oct; 43(1):71-82.e6. PubMed ID: 29017031
[TBL] [Abstract][Full Text] [Related]
18. Mitogen-activated protein kinases promote WNT/beta-catenin signaling via phosphorylation of LRP6.
Červenka I; Wolf J; Mašek J; Krejci P; Wilcox WR; Kozubík A; Schulte G; Gutkind JS; Bryja V
Mol Cell Biol; 2011 Jan; 31(1):179-89. PubMed ID: 20974802
[TBL] [Abstract][Full Text] [Related]
19. Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.
Nagaoka T; Karasawa H; Turbyville T; Rangel MC; Castro NP; Gonzales M; Baker A; Seno M; Lockett S; Greer YE; Rubin JS; Salomon DS; Bianco C
Cell Signal; 2013 Jan; 25(1):178-89. PubMed ID: 23022962
[TBL] [Abstract][Full Text] [Related]
20. Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6) Is a Novel Nutritional Therapeutic Target for Hyperlipidemia, Non-Alcoholic Fatty Liver Disease, and Atherosclerosis.
Go GW
Nutrients; 2015 Jun; 7(6):4453-64. PubMed ID: 26046396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
